Latest stock market news videos & Morning Bell

Interviews

From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.

Bell Direct

March 20, 2026

In this episode of From the Helm, Grady is joined by Amplia Therapeutics (ASX:ATX) CEO & MD Dr Christopher Burns & Bell Potter Analyst Thomas Wakim to unpack the ongoing clinical trials for their prospective treatment drug for pancreatic cancer, and its substantial market opportunities in the US.

Market Wraps

Weekly Wrap 24 April

Bell Direct

April 24, 2026

Market Wraps

Weekly Wrap 17 April

Bell Direct

April 17, 2026

Interviews

From the helm: Centaurus Metals (ASX:CTM), CEO & MD, Darren Gordon

Bell Direct

April 2, 2026

Interviews

From the helm: Oneview Healthcare (ASX:ONE), CEO, James Fitter

Bell Direct

April 2, 2026

Interviews

From the helm: Titomic Ltd, CFO, Geoff Hollis

Bell Direct

April 1, 2026

Interviews

From the helm: Artrya Limited (ASX:AYA): John Konstantopoulos, CEO & Co-Founder

Bell Direct

April 1, 2026

Interviews

From the helm: Bell Financial Group (ASX:BFG): Arnie Selvarajah, Group Co-CEO

Bell Direct

April 1, 2026

Market Wraps

Navigating geopolitical turbulence:The strategic case for defence technology

Bell Direct

March 31, 2026

Market Wraps

Weekly Wrap 27 March

Bell Direct

March 27, 2026

Interviews

From the helm: Summerset Group Holdings (ASX:SNZ), CFO, Margaret Warrington.

Bell Direct

March 20, 2026

Interviews

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

Bell Direct

March 20, 2026

Interviews

From the helm: Neuren Pharmaceuticals (ASX:NEU), CEO, Jon Pilcher.

Bell Direct

March 20, 2026